Soni Kumari

Name : Mrs Soni Kumari (44Y/F)
Date : 09 Nov 2024
Test Asked : Aarogyam Camp Profile 2
Report Status: Complete Report

PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004
NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

REF. BY : SELF
(8420027368),SHree KRISHNA HEALTH
TEST ASKED : AAROGYAM CAMP PROFILE 2 services,Near mithanpura railway gumti
mithanpura chowk muzaffarpur bihar,842002
Report Availability Summary

Note: Please refer to the table below for status of your tests.
10 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab
TEST DETAILS REPORT STATUS
AAROGYAM CAMP PROFILE 2 Ready
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) Ready
Lipoprotein (a) [Lp(a)] Ready
HBA PROFILE Ready
HEMOGRAM - 6 PART (DIFF) Ready
LIVER FUNCTION TESTS Ready
KIDPRO Ready
LIPID PROFILE Ready
T3-T4-USTSH Ready
VITAMIN D TOTAL AND B12 COMBO Ready
APOLIPROTEIN RATIO Ready

PROCESSED AT :
Thyrocare
Patna–800 004

REF. BY : SELF (8420027368),SHree KRISHNA HEALTH services,Near
TEST ASKED : AAROGYAM CAMP PROFILE 2 mithanpura railway gumti mithanpura chowk muzaffarpur
bihar,842002
Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) 8.3 mg/L <3
TRIG / HDL RATIO 3.25 Ratio < 3.12
COMPLETE HEMOGRAM
EOSINOPHILS 10.9 % 1-6
HEMOGLOBIN 11.7 g/dL 12.0-15.0
MEAN CORP.HEMO.CONC(MCHC) 30.1 g/dL 31.5-34.5
MEAN PLATELET VOLUME(MPV) 13.4 fL 6.5-12
MONOCYTES - ABSOLUTE COUNT 0.11 X 10³ / µL 0.2 - 1.0
PLATELET DISTRIBUTION WIDTH(PDW) 18.8 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 51.9 % 19.7-42.4
RED CELL DISTRIBUTION WIDTH (RDW-CV) 16.6 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 56.6 fL 39.0-46.0
TOTAL LEUCOCYTES COUNT (WBC) 3.95 X 10³ / µL 4.0 - 10.0
LIPID
HDL / LDL RATIO 0.25 Ratio > 0.40
HDL CHOLESTEROL - DIRECT 35 mg/dL 40-60
LDL / HDL RATIO 4 Ratio 1.5-3.5
LDL CHOLESTEROL - DIRECT 139 mg/dL < 100
TC/ HDL CHOLESTEROL RATIO 5.4 Ratio 3-5
LIVER
ALANINE TRANSAMINASE (SGPT) 422.8 U/L < 34
ASPARTATE AMINOTRANSFERASE (SGOT ) 398.2 U/L < 31
GAMMA GLUTAMYL TRANSFERASE (GGT) 70 U/L < 38
RENAL
CALCIUM 8.41 mg/dL 8.8-10.6
URIC ACID 6.23 mg/dL 3.2 - 6.1
THYROID
TOTAL THYROXINE (T4) 12.9 µg/dL 4.8-12.7
VITAMINS
25-OH VITAMIN D (TOTAL) 20 ng/mL 30-100
VITAMIN B-12 174 pg/mL 197-771
Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
Patna–800 004

REF. BY (8420027368),SHree KRISHNA HEALTH
: SELF
services,Near mithanpura railway gumti
TEST ASKED : AAROGYAM CAMP PROFILE 2 mithanpura chowk muzaffarpur bihar,842002
TEST NAME TECHNOLOGY VALUE UNITS
25-OH VITAMIN D (TOTAL) E.C.L.I.A 20 ng/mL

Bio. Ref. Interval. :
Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml
Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for building
bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.
Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

VITAMIN B-12 E.C.L.I.A 174 pg/mL
Normal: 197-771 pg/ml
Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It
is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find
out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be
assessed in conjunction with the patients medical history, clinical examination and other findings.
Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %
Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Please correlate with clinical conditions.
Sample Collected on (SCT) : 09 Nov 2024 15:56
Sample Received on (SRT) : 09 Nov 2024 23:44

Report Released on (RRT) : 10 Nov 2024 07:58
Sample Type : SERUM
Labcode : 0911111500/AD664 Dr T Priyanka MD(Path) Dr R Kumar MD (Path)
Barcode : CU214180
Page : 1 of 12
PROCESSED AT :
Thyrocare
Patna–800 004

: SELF
TEST ASKED : AAROGYAM CAMP PROFILE 2 mithanpura chowk muzaffarpur bihar,842002
APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 106 mg/dL

Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 117 mg/dL
Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APO B / APO A1 RATIO (APO B/A1) CALCULATED 1.1 Ratio
Male : 0.40 - 1.26
Female : 0.38 - 1.14
Method : Derived from serum Apo A1 and Apo B values


Sample Type : SERUM
Barcode : CU214180
Page : 2 of 12
PROCESSED AT :
Thyrocare
Patna–800 004

REF. BY : SELF (8420027368),SHree KRISHNA HEALTH
TEST ASKED : AAROGYAM CAMP PROFILE 2

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 8.3 mg/L
Bio. Ref. Interval. :-
< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation
Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.
Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.
Kit Validation Reference:

1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Type : SERUM
Dr T Priyanka MD(Path) Dr R Kumar MD (Path)
Labcode : 0911111500/AD664
Barcode : CU214180 Page : 3 of 12
PROCESSED AT :
Thyrocare
Patna–800 004


LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 17.2 mg/dL
Adults : < 30.0 mg/dl
Clinical Significance:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.
Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %
Kit Validation Reference:

Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Type : SERUM
Labcode : 0911111500/AD664
PROCESSED AT :
Thyrocare
Patna–800 004

REF. BY (8420027368),SHree KRISHNA HEALTH services,Near
: SELF
mithanpura railway gumti mithanpura chowk
TEST ASKED : AAROGYAM CAMP PROFILE 2 muzaffarpur bihar,842002
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 188 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 35 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 139 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 114 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 5.4 Ratio 3-5
TRIG / HDL RATIO CALCULATED 3.25 Ratio < 3.12
LDL / HDL RATIO CALCULATED 4 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.25 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 153.34 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 22.79 mg/dL 5 - 40
Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Type : SERUM

PROCESSED AT :
Thyrocare
Patna–800 004

: SELF

ALKALINE PHOSPHATASE PHOTOMETRY 117.8 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.43 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.34 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 70 U/L < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 398.2 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 422.8 U/L < 34
SGOT / SGPT RATIO CALCULATED 0.94 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 6.8 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.87 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.93 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.32 Ratio 0.9 - 2
Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Type : SERUM

PROCESSED AT :
Thyrocare
Patna–800 004

: SELF

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 8.35 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.6 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 13.92 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 17.87 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 29.78 Ratio < 52
CALCIUM PHOTOMETRY 8.41 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 6.23 mg/dL 3.2 - 6.1
Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Sample Type : SERUM

PROCESSED AT :
Thyrocare
Patna–800 004

(8420027368),SHree KRISHNA HEALTH services,Near
REF. BY : SELF

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 168 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 12.9 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 1.87 µIU/mL 0.54-5.30
Comments : IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay
Pregnancy reference ranges for TSH/USTSH :
Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as
Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian
women with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research.
2019; 6(4)
Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Type : SERUM
PROCESSED AT :
Thyrocare
Patna–800 004


EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 111 mL/min/1.73 m2
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Method:- CKD-EPI Creatinine Equation

Sample Type : SERUM
Labcode : 0911111500/AD664
PROCESSED AT :
Thyrocare
Patna–800 004

: SELF
TEST ASKED : HBA PROFILE,HEMOGRAM mithanpura chowk muzaffarpur bihar,842002

HbA1c - (HPLC)
H.P.L.C 5.6 %
Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 115 mg/dL
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values


Sample Type : EDTA Whole Blood
Barcode : BG571550
Page : 10 of 12
PROCESSED AT :
Thyrocare
Patna–800 004

services,Near mithanpura railway gumti mithanpura
TEST ASKED : HBA PROFILE,HEMOGRAM
chowk muzaffarpur bihar,842002
TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 11.7 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 38.9 % 36.0-46.0
Total RBC HF & EI 4.19 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 92.8 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 27.9 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 30.1 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 56.6 fL 39.0-46.0
Red Cell Distribution Width (RDW - CV) Calculated 16.6 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 367.7 - *Refer Note below
MENTZER INDEX Calculated 22.1 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 3.95 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 53.3 % 40-80
Lymphocytes Percentage Flow Cytometry 31.9 % 20-40
Monocytes Percentage Flow Cytometry 2.8 % 2-10
Eosinophils Percentage Flow Cytometry 10.9 % 1-6
Basophils Percentage Flow Cytometry 0.8 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 2.11 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 1.26 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.11 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.03 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.43 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.01 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 178 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 13.4 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 18.8 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 51.9 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.24 % 0.19-0.39
Remarks : Alert!!! RBCs:Mild anisopoikilocytosis. Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.
*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)
~~ End of report ~~

Sample Type : EDTA Whole Blood
Barcode : BG571550 Page : 11 of 12
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)
Page : 12 of 12

Soni Kumari

Uploaded by

Copyright:

Available Formats

Soni Kumari

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Soni Kumari

Uploaded by

Copyright:

Available Formats

Name : Mrs Soni Kumari (44Y/F)

Date : 09 Nov 2024

Test Asked : Aarogyam Camp Profile 2

Report Status: Complete Report

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

Report Availability Summary

10 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

AAROGYAM CAMP PROFILE 2 Ready

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) Ready

Lipoprotein (a) [Lp(a)] Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

LIPID PROFILE Ready

VITAMIN D TOTAL AND B12 COMBO Ready

APOLIPROTEIN RATIO Ready

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 20 ng/mL

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Collected on (SCT) : 09 Nov 2024 15:56

Sample Received on (SRT) : 09 Nov 2024 23:44

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 106 mg/dL

Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

Method : Derived from serum Apo A1 and Apo B values

Sample Collected on (SCT) : 09 Nov 2024 15:56

Sample Received on (SRT) : 09 Nov 2024 23:44

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

< 1.00 - Low Risk

Kit Validation Reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 09 Nov 2024 15:56

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Adults : < 30.0 mg/dl

Kit Validation Reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 09 Nov 2024 15:56

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

Sample Collected on (SCT) : 09 Nov 2024 15:56

Barcode : CU214180 Page : 5 of 12

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

Sample Collected on (SCT) : 09 Nov 2024 15:56

Barcode : CU214180 Page : 6 of 12

NAME : MRS SONI KUMARI (44Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

Sample Collected on (SCT) : 09 Nov 2024 15:56

Barcode : CU214180 Page : 7 of 12